U.S., June 17 -- ClinicalTrials.gov registry received information related to the study (NCT07649512) titled 'Progressive Muscle Relaxation Delivered Via Virtual Reality - an Intervention for Patients Undergoing Cellular Therapy' on Jan. 08.
Brief Summary: Patients planned for cellular therapy supplementation such as CAR-T or stem cell transplant who are admitted for atleast 7 days in patient. During that time of admission, patients enrolled will complete a once daily, virtual reality guided progressive muscle relaxation program. Various validated QOL tools will be utilized to assess study results.
Study Start Date: Aug., 2026
Study Type: INTERVENTIONAL
Condition:
Heme Malignancy
Intervention:
COMBINATION_PRODUCT: Progressive Muscle R...